BF
CDNA icon

BOK Financial’s CareDx CDNA Stock Holding History

BOK Financial’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-250
Closed -$5.91K – 1294
2024
Q4 		$5.91K Buy
+250
New +$6.08K ﹤0.01% 1026

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BOK Financial's CDNA Position: Q1 2025 in Review

BOK Financial sold out of CareDx (CDNA) in Q1 2025, closing a stake of 250 shares — an estimated $5.91K sold.

BOK Financial first reported a position in CDNA in Q4 2024 and held it in 1 quarter. The position peaked at $5.91K in Q4 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • BOK Financial reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • BOK Financial sold 250 CareDx shares in Q1 2025, an estimated $5.91K.
  • BOK Financial first reported a position in CareDx in Q4 2024 and held it in 1 quarter.
  • BOK Financial's CareDx position peaked at $5.91K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on BOK Financial's 13F filing for Q1 2025, filed 13 May 2025.